Alignment Healthcare Future Growth
Future criteria checks 1/6
Alignment Healthcare is forecast to grow earnings and revenue by 41.9% and 18.3% per annum respectively. EPS is expected to grow by 42.4% per annum. Return on equity is forecast to be -82% in 3 years.
Key information
41.9%
Earnings growth rate
42.4%
EPS growth rate
| Healthcare earnings growth | 17.0% |
| Revenue growth rate | 18.3% |
| Future return on equity | -82.0% |
| Analyst coverage | Good |
| Last updated | 24 Jun 2024 |
Recent future growth updates
Recent updates
An Intrinsic Calculation For Alignment Healthcare, Inc. (NASDAQ:ALHC) Suggests It's 26% Undervalued
Jun 20
The Market Lifts Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares 37% But It Can Do More
May 30Is Alignment Healthcare (NASDAQ:ALHC) Weighed On By Its Debt Load?
Apr 19It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)
Feb 24Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?
Jan 18Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity
Nov 08Alignment Healthcare: Investors Should Align Themselves With Insiders
Oct 05Alignment Healthcare announces 9M shares secondary offering
Sep 15Alignment Healthcare completes debt refinancing
Sep 06Alignment Healthcare: This Next-Generation Medicare Startup Is Fully Valued
Aug 22Alignment Health Plan plans to expand into three Nevada counties
Jul 20Alignment Healthcare Grows Revenue But Operating Losses Remain
May 17Earnings Release: Here's Why Analysts Cut Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$15.75
Mar 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3,747 | -72 | 28 | 87 | 9 |
| 12/31/2025 | 3,108 | -96 | 14 | 67 | 11 |
| 12/31/2024 | 2,523 | -127 | -26 | -3 | 11 |
| 3/31/2024 | 2,013 | -157 | -190 | -151 | N/A |
| 12/31/2023 | 1,824 | -148 | -95 | -59 | N/A |
| 9/30/2023 | 1,720 | -158 | -53 | -21 | N/A |
| 6/30/2023 | 1,624 | -163 | 49 | 78 | N/A |
| 3/31/2023 | 1,528 | -146 | 25 | 51 | N/A |
| 12/31/2022 | 1,434 | -150 | -69 | -45 | N/A |
| 9/30/2022 | 1,371 | -140 | 53 | 74 | N/A |
| 6/30/2022 | 1,304 | -146 | -38 | -19 | N/A |
| 3/31/2022 | 1,246 | -179 | -73 | -52 | N/A |
| 12/31/2021 | 1,168 | -195 | -99 | -79 | N/A |
| 9/30/2021 | 1,112 | -180 | -80 | -59 | N/A |
| 6/30/2021 | 1,066 | -123 | -66 | -46 | N/A |
| 3/31/2021 | 1,002 | -70 | -26 | -9 | N/A |
| 12/31/2020 | 959 | -23 | -8 | 8 | N/A |
| 12/31/2019 | 757 | -45 | -1 | 9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALHC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALHC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALHC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ALHC's revenue (18.3% per year) is forecast to grow faster than the US market (8.6% per year).
High Growth Revenue: ALHC's revenue (18.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALHC is forecast to be unprofitable in 3 years.